Profound MedicalPROF -1.16%73 Earnings Yield (Joel Greenblatt) % is -19.80% as of Mar. 2026. GuruFocus rates PROF with a GF Score™ of 73/100 and a GF Value™ of $14.28 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 856 Medical Devices & Instruments companies, Profound Medical ranks worse than 79.91% on this metric.
Profound Medical's Enterprise Value for the quarter that ended in Mar. 2026 was $192.64 Mil.
Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-38.11 Mil. Profound Medical's Earnings Yield (Joel Greenblatt) for the quarter that ended in Mar. 2026 was -19.80%.
The historical rank and industry rank for Profound Medical's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
PROF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -111.85 Med: -20.02 Max: -4.66
Current: -17.18
During the past 12 years, the highest Earnings Yield (Joel Greenblatt) of Profound Medical was -4.66%. The lowest was -111.85%. And the median was -20.02%.
PROF's Earnings Yield (Joel Greenblatt) % is ranked worse than 79.91% of 856
companies
in the Medical Devices & Instruments industry
Industry Median: 0.74
vs PROF: -17.18
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Profound Medical's Forward Rate of Return (Yacktman) % for the quarter that ended in Mar. 2026 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Profound Medical (NAS:PROF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Profound Medical Earnings Yield (Joel Greenblatt) % Related Terms
Profound Medical Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Profound Medical's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Profound Medical Earnings Yield (Joel Greenblatt) % Chart
For the Medical Devices subindustry, Profound Medical's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profound Medical Earnings Yield (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Profound Medical's Earnings Yield (Joel Greenblatt) % falls into.
Profound Medical Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Profound Medicals Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2025 is calculated as
Profound Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-38.11 Mil.
What does a Earnings Yield (Joel Greenblatt) % of -19.80% mean?
Profound Medical (PROF) has a Earnings Yield (Joel Greenblatt) % of -19.80% as of Mar. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Profound Medical and its competitors. According to the industry distribution chart, Profound Medical ranks #684 out of 856 companies in the Medical Devices & Instruments industry, placing it in the top 79.9%.
Is Profound Medical's Earnings Yield (Joel Greenblatt) % too high?
Profound Medical's current Earnings Yield (Joel Greenblatt) % is -19.80%. Based on the distribution chart, Profound Medical ranks #684 out of 856 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Profound Medical has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's Earnings Yield (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Profound Medical ranks #684 out of 856 companies for Earnings Yield (Joel Greenblatt) %. This places Profound Medical in the lower half of its industry. The industry median Earnings Yield (Joel Greenblatt) % is 0.74. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median Earnings Yield (Joel Greenblatt) % among Medical Devices & Instruments companies is 0.74, based on 856 companies in the industry. Companies in the top quartile (top 25%) have a Earnings Yield (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on Profound Medical and its competitors. For the Medical Devices & Instruments industry, the median Earnings Yield (Joel Greenblatt) % is 0.74 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profound Medical's current Earnings Yield (Joel Greenblatt) % is -19.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (PROF) is currently considered Possible Value Trap. The stock's GF Value™ is $14.28, compared to a current price of $7.25 — trading 49.2% below its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is -19.80%. Profound Medical's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For Profound Medical (PROF), the current Earnings Yield (Joel Greenblatt) % is -19.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profound Medical (PROF) Overvalued in 2026?
Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued.
The current stock price of $7.25 is trading 49.2% below its estimated GF Value™ of $14.28.
GuruFocus considers Profound Medical to be Possible Value Trap.
Key valuation signals for PROF:
Earnings Yield (Joel Greenblatt) %: -19.80%
GF Value™: $14.28 vs. price of $7.25 (49.2% below fair value)
No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
73GF Score
Get the complete analysis for PROF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PROF has been successfully added to your 
